Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hamm

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Clinical Oncology|August 19, 2009
A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinomaElena G Chiorean, Tomislav Dragovich, John Hamm, et al.
Clinical Lung Cancer|March 17, 2020
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based ChemotherapySusanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al.
Cancer|October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumorsAung Naing, Alain P Algazi, Gerald S Falchook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.
JAMA Surgery|April 15, 2026
An American College of Surgeons National Quality Improvement Collaborative to Enhance Lung Cancer Surgical QualityKelley Chan, Eileen M Reilly, Ryan C Jacobs, et al.
Journal for Immunotherapy of Cancer|October 30, 2023
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trialCaicun Zhou, Minu K Srivastava, Hao Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and NeckJohn Nemunaitis, Gary Clayman, Sanjiv S Agarwala, et al.
JCO Global Oncology|May 7, 2020
International Perspective on the Pursuit of Quality in Cancer Care: Global Application of QOPI and QOPI CertificationDouglas W Blayney, Nafisa Albdelhafeez, Abdul Rahman Jazieh, et al.
Nature Medicine|March 28, 2026
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trialByoung Chul Cho, Rama Balaraman, Hua-Jun Chen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Clinical Oncology|August 19, 2009
A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinomaElena G Chiorean, Tomislav Dragovich, John Hamm, et al.
Clinical Lung Cancer|March 17, 2020
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based ChemotherapySusanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al.
Cancer|October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumorsAung Naing, Alain P Algazi, Gerald S Falchook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.
JAMA Surgery|April 15, 2026
An American College of Surgeons National Quality Improvement Collaborative to Enhance Lung Cancer Surgical QualityKelley Chan, Eileen M Reilly, Ryan C Jacobs, et al.
Journal for Immunotherapy of Cancer|October 30, 2023
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trialCaicun Zhou, Minu K Srivastava, Hao Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and NeckJohn Nemunaitis, Gary Clayman, Sanjiv S Agarwala, et al.
JCO Global Oncology|May 7, 2020
International Perspective on the Pursuit of Quality in Cancer Care: Global Application of QOPI and QOPI CertificationDouglas W Blayney, Nafisa Albdelhafeez, Abdul Rahman Jazieh, et al.
Nature Medicine|March 28, 2026
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trialByoung Chul Cho, Rama Balaraman, Hua-Jun Chen, et al.
Pageof 2